Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow CareDx, Inc.

Get SEC filing alerts via email and in your feed for CareDx, Inc.

CDNA

CareDx, Inc.

About CareDx, Inc.

CareDx is a precision medicine company specializing in the discovery, development, and commercialization of high-value diagnostic solutions for transplant patients. Its core offerings include molecular diagnostic tests, digital patient management tools, and lab products that improve transplant outcomes. Serving transplant centers and healthcare providers primarily in the U.S. and Europe, CareDx leverages genomic technologies and data-driven solutions to enhance organ rejection detection, patient monitoring, and operational efficiency.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from CareDx, Inc.

1
1
CareDx, Inc. CareDx Reports 39% Revenue Growth to $117.7 Million, Achieves Net Income Turnaround

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
CareDx, Inc. CareDx Reports $380 Million Revenue with 14% Growth, Faces $21.4 Million Net Loss in 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
CareDx, Inc. CareDx Reports 21% Revenue Growth to $100.1 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
CareDx, Inc. CareDx Reports Q2 2025 Revenue of $86.7 Million, Net Loss of $8.6 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
CareDx, Inc. CareDx Reports 18% Revenue Growth to $84.7 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
CareDx, Inc. CareDx Reports $52.5 Million Net Income Turnaround for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
CareDx, Inc. CareDx Reports 23% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments